Exhibit Hall

HomeAttendeesExhibit Hall ▶ Guru Bars
Guru Bars

Sunday, May 20, 2018
Monday, May 21, 2018
Tuesday, May 22, 2018

Sunday, May 20, 2018

San Diego Convention Center

Guru Bar 1 - Education/Awareness/Prevention or Diagnosis

11:30 AM - 12:00 PM


Insights on Type 2 Inflammation: The Connection to Airway Pathology

The primary objective of this brief presentation is to increase HCP understanding of Type 2 inflammation and how it contributes to airway pathology in asthma. Evidence supporting roles for Type 2 cytokines in epithelial and airway smooth muscle pathology including remodeling, fibrosis, mucus production and airway hyper-responsiveness will be discussed.

Company: Sanofi Genzyme & Regeneron


12:30 PM - 01:00 PM


Introducing Rad Rounds – UIP to IPF: A Digital Application to Identify Usual Interstitial Pneumonia on HRCT Limited to healthcare professionals.

In this digitally-enhanced Guru Bar, an expert pulmonologist and radiologist will introduce the recently-launched Rad Rounds – UIP to IPF app. Working in tandem, these distinguished faculty will review the radiology content contained in the app, including the diagnostic algorithm, to improve recognition of usual interstitial pneumonia (UIP), a radiologic pattern associated with idiopathic pulmonary fibrosis (IPF). Authentic examples of UIP, as well as other hallmarks will be shown.

Speakers: Marilyn K. Glassberg MD University of Miami Miller School of Medicine; Robert Suh MD Ronald Reagan UCLA Medical Center

Company: Boehringer Ingelheim Pharmaceuticals, Inc.


01:30 PM - 02:00 PM


Challenges of Early Stage Lung Cancer Treatment and Recurrence

Clinicians face numerous challenges in the management of patients with early stage lung cancer. One of the most difficult aspects is determining the risk of recurrence for early stage patients that are treated surgically. Current treatment options have limited effectiveness and diagnostic tools often provide very limited recurrence risk information. During this interactive, case-based Guru Bar you will hear from experts in the field regarding the need for new biomarkers to better assess the risk of recurrence and their future role in clinical practice.

Speaker: Jeff Thompson MD Hospital of the University of Pennsylvania

Company: OncoCyte Corporation


Guru Bar 2 - Education/Awareness/Prevention or Diagnosis

12:00 PM - 12:30 PM


(Open to U.S. attendees only)

Company: Mallinckrodt Pharmaceuticals


01:00 PM - 01:30 PM


The Future of Lung Cancer and the Monarch Platform

Introduction of the Monarch Platform

Speaker: Thomas Gildea MD Cleveland Clinic

Company: Auris


Guru Bar 3 - Treatment or Adherence/Compliance

01:30 PM - 02:00 PM


A New Treatment Option in Distributive Shock (Open to U.S. attendees only)

In distributive shock adequate fluid therapy and appropriate doses of vasopressors often do not result in achievement or maintenance of target mean arterial pressure. Join us as we discuss distributive shock, including the current stepwise approach to managing patients, and an overview of the renin angiotensin aldosterone system as another potential target to help manage hypotension.

Speaker: H. Bryant Nguyen MD, MS Loma Linda University Medical Center

Company: La Jolla Pharmaceutical Company


Guru Bar 4 - Treatment or Adherence/Compliance

01:00 PM - 01:30 PM


A New Treatment Option in Distributive Shock (Open to U.S. attendees only)

In distributive shock adequate fluid therapy and appropriate doses of vasopressors often do not result in achievement or maintenance of target mean arterial pressure. Join us as we discuss distributive shock, including the current stepwise approach to managing patients, and an overview of the renin angiotensin aldosterone system as another potential target to help manage hypotension.

Speaker: H. Bryant Nguyen MD, MS Loma Linda University Medical Center

Company: La Jolla Pharmaceutical Company


Monday, May 21, 2018

San Diego Convention Center

Guru Bar 1 - Education/Awareness/Prevention or Diagnosis

12:30 PM - 01:00 PM


More than an Airway Problem? Understanding Excessive Sleepiness (ES) in Obstructive Sleep Apnea (OSA)

Emerging science suggests that one potential cause of excessive sleepiness (ES) in obstructive sleep apnea (OSA) may be alterations to wake-promoting regions of the brain resulting from chronic intermittent hypoxia and sleep fragmentation. This presentation provides an overview of several relevant studies on this topic. Prevalence and consequences of ES in OSA are also discussed, as well as information related to tools for assessment of ES in clinical practice.

Speaker: Terri E. Weaver PhD, RN University of Illinois at Chicago, College of Nursing

Company: Jazz Pharmaceuticals, Inc


Guru Bar 2 - Education/Awareness/Prevention or Diagnosis

12:00 PM - 12:30 PM


Can you make the Diagnosis?

Definition, pathology, and pathobiology of WHO group; PAH and the diagnostic evaluation of suspected PAH. Supported by Actelion Pharmaceuticals, a Janssen Pharmaceutical Company of Johnson and Johnson through a independent medical education grant.

Speaker: Vallerie V McLaughlin MD University of Michigan

Company: AKH Inc., Advancing Knowledge in Healthcare


01:00 PM - 01:30 PM


Breaking the Vicious Cycle of non-CF Bronchiectasis: The Role of Airway Clearance Therapy

Dr. Alan F. Barker will discuss the diagnosis and treatment of non-CF Bronchiectasis with a focus on the role of airway clearance therapy in breaking the vicious cycle of non-CF Bronchiectasis and recurrent chest infections. Prevalence of non-CF Bronchiectasis in the US COPD population, symptoms, and confirmation of the disease by a High-Resolution CT scan will be discussed. Dr. Barker will also provide an overview of treatment options including High Frequency Chest Wall Oscillation airway clearance vest therapy.

Speaker: Alan F. Barker MD Oregon Health & Science University

Company: International Biophysics


Guru Bar 3 - Treatment or Adherence/Compliance

12:30 PM - 01:00 PM


Concomitant Idiopathic Pulmonary Fibrosis and Emphysema: Strategies to Improve Patient Management Limited to healthcare professionals.

This town hall-style Guru Bar will educate attendees on the presence of concomitant emphysema in some patients with IPF. Program will also provide an opportunity to discuss management strategies with an expert pulmonologist. Topics to be discussed will include management and compliance issues faced by patients with CPFE and strategies to address them.

Speaker: Lucas Pitts MD University of Kansas Medical Center

Company: Boehringer Ingelheim Pharmaceuticals, Inc.


Guru Bar 4 - Treatment or Adherence/Compliance

01:00 PM - 01:30 PM


Challenges and Choices in the Management of PAH

Treatment pathways, available treatments, long-term outcomes and predictors of survival in PAH. Supported by Actelion Pharmaceuticals, a Janssen Pharmaceutical Company of Johnson and Johnson through a independent medical education grant.

Speaker: Vallerie V McLaughlin MD University of Michigan

Company: AKH Inc., Advancing Knowledge in Healthcare


Tuesday, May 22, 2018

San Diego Convention Center

Guru Bar 1 - Education/Awareness/Prevention or Diagnosis

12:30 PM - 01:00 PM


More than an Airway Problem? Understanding Excessive Sleepiness (ES) in Obstructive Sleep Apnea (OSA)

Emerging science suggests that one potential cause of excessive sleepiness (ES) in obstructive sleep apnea (OSA) may be alterations to wake-promoting regions of the brain resulting from chronic intermittent hypoxia and sleep fragmentation. This presentation provides an overview of several relevant studies on this topic. Prevalence and consequences of ES in OSA are also discussed, as well as information related to tools for assessment of ES in clinical practice.

Speaker: Terri E. Weaver PhD, RN University of Illinois at Chicago, College of Nursing

Company: Jazz Pharmaceuticals, Inc